Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELLIPTA DPI Usability in Pediatric Asthma
NCT03478657Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial, sponsored by GSK. Primary endpoints: Percentage of Participants From Each Stratum Who Demonstrated Correct Use of the ELLIPTA DPI at Visit 2, Attempt 1 at Day 28 and Percentage of Participants Who Rated the ELLIPTA DPI as Easy to Use Among Those Who Could Demonstrate Correct Use at Visit 2, Attempt 1 at Day 28. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03478657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478657.